FDA grants breakthrough device designation for Natera’s multi-cancer early detection assay
NTRA•The FDA granted breakthrough device designation to Natera’s multi-cancer early detection assay.
1. FDA designation
The FDA granted breakthrough device designation to Natera’s multi-cancer early detection assay.
